Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.52 |
| ▸ | ITGB2 | P05107 | 1/20 | 0.52 |
| ▸ | ICAM1 | P05362 | 1/20 | 0.52 |
| ▸ | ITGAL | P20701 | 1/20 | 0.52 |
| ▸ | MAOB | P27338 | 3/20 | 0.46 |
| ▸ | MAOA | P21397 | 2/20 | 0.46 |
| ▸ | LMNA | P02545 | 3/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.46 |
| ▸ | CRHBP | P24387 | 2/20 | 0.46 |
| ▸ | CRHR2 | Q13324 | 2/20 | 0.46 |
| ▸ | HTT | P42858 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 2/20 | 0.44 |
| ▸ | PKM | P14618 | 1/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.43 |
| ▸ | DAPK3 | O43293 | 1/20 | 0.41 |
| ▸ | RET | P07949 | 1/20 | 0.41 |
| ▸ | PRKACA | P17612 | 1/20 | 0.41 |
| ▸ | GRK5 | P34947 | 1/20 | 0.41 |
| ▸ | CDK8 | P49336 | 1/20 | 0.41 |
| ▸ | GSK3A | P49840 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30450885 | 0.80 | CYP1A2 (0.54) | ABCG2ITGB2ICAM1ITGALMAOB | |
| SCHEMBL3962887 | 0.80 | CYP1A2 (0.54) | ABCG2ITGB2ICAM1ITGALMAOB | |
| SCHEMBL6108899 | 0.79 | CYP2A6 (0.50) | ABCG2ITGB2ICAM1ITGALMAOB | |
| SCHEMBL279547 | 0.77 | ABCG2 (0.46) | ABCG2ITGB2ICAM1ITGALMAOB | |
| SCHEMBL29966720 | 0.77 | ABCG2 (0.46) | ABCG2ITGB2ICAM1ITGALMAOB | |
| SCHEMBL10460744 | 0.75 | PKM (0.48) | MAOBMAOASMN1; SMN2TSHRPKM | |
| SCHEMBL6068686 | 0.74 | OXTR (0.37) | ABCG2ITGB2ICAM1ITGALMAOB | |
| SCHEMBL15569568 | 0.74 | GAA (0.52) | MAOBMAOATSHRPKMALOX5 | |
| SCHEMBL1593497 | 0.74 | MAOB (0.39) | ABCG2ITGB2ICAM1ITGALMAOB | |
| SCHEMBL6569085 | 0.74 | MAP3K14 (0.36) | SMN1; SMN2TSHRNPC1RAB9AALOX5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 178 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109640937-B | Antiperspirant or deodorant compositions | 弗门尼舍有限公司 | 2022-06-14 | — | — | CN | claimed |
| CN-114096235-A | Antimicrobial compositions | 弗门尼舍有限公司 | 2022-02-25 | — | — | CN | claimed |
| CN-110099993-B | High impact perfume microcapsules of balanced density | 弗门尼舍有限公司 | 2021-08-24 | — | — | CN | claimed |
| US-10336966-B2 | Fragrance compositions and uses thereof | THE PROCTER & GAMBLE COMPANY (US) | 2019-07-02 | — | — | US | claimed |
| WO-2018145219-A1 | PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING ADDICTIONS BY MEANS OF AVERSIVE COUNTERCONDITIONING | SERANI MOSTAZAL JORGE (CL) | 2018-08-16 | — | — | WO | claimed |
| US-9814661-B2 | Fragrance compositions | THE PROCTER & GAMBLE COMPANY (US) | 2017-11-14 | — | — | US | claimed |
| EP-3197424-A1 | FRESHENING COMPOSITIONS AND DEVICES COMPRISING SAME | THE PROCTER & GAMBLE COMPANY (US) | 2017-08-02 | — | — | EP | claimed |
| EP-2961374-B1 | FRAGRANCE COMPOSITIONS | PROCTER & GAMBLE (US) | 2017-01-25 | — | — | EP | claimed |
| WO-2016049398-A1 | FRESHENING COMPOSITIONS AND DEVICES COMPRISING SAME | THE PROCTER & GAMBLE COMPANY (US) | 2016-03-31 | — | — | WO | claimed |
| EP-2961374-A1 | FRAGRANCE COMPOSITIONS | The Procter & Gamble Company (US) | 2016-01-06 | — | — | EP | claimed |
| US-8754028-B2 | Perfume systems | THE PROCTER & GAMBLE COMPANY (US) | 2014-06-17 | — | — | US | claimed |
| WO-2013053102-A1 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | GIVAUDAN SA (CH) | 2013-04-18 | — | — | WO | claimed |
| US-20100152083-A1 | Perfume Systems | PROCTER & GAMBLE COMPANY, THE | 2010-06-17 | — | — | US | claimed |
| EP-2162525-A1 | PERFUMED HOUSEHOLD PRODUCTS AND METHODS FOR PRESERVING PERFUME INTEGRITY AND EXTENDING FRAGRANCE LIFE | The Procter & Gamble Company (US) | 2010-03-17 | — | — | EP | claimed |
| US-20090218251-A1 | PERFUMED HOUSEHOLD PRODUCTS AND METHODS FOR PRESERVING PERFUME INTEGRITY AND EXTENDING FRAGRANCE LIFE | WOO RICKY AH-MAN | 2009-09-03 | — | — | US | claimed |
| US-7550416-B2 | Perfumed household products and methods for preserving perfume integrity and extending fragrance life | THE PROCTER & GAMBLE COMPANY (US) | 2009-06-23 | — | — | US | claimed |
| US-20090000979-A1 | Perfumed household products and methods for preserving perfume integrity and extending fragrance life | PROCTER & GAMBLE COMPANY, THE | 2009-01-01 | — | — | US | claimed |
| US-20090005280-A1 | PERFUMED HOUSEHOLD PRODUCTS AND METHODS FOR PRESERVING PERFUME INTEGRITY AND EXTENDING FRAGRANCE LIFE | PROCTER & GAMBLE COMPANY, THE | 2009-01-01 | — | — | US | claimed |
| WO-2009001320-A1 | PERFUMED HOUSEHOLD PRODUCTS AND METHODS FOR PRESERVING PERFUME INTEGRITY AND EXTENDING FRAGRANCE LIFE | THE PROCTER & GAMBLE COMPANY (US) | 2008-12-31 | — | — | WO | claimed |
| EP-1405851-A1 | Method for producing seven-membered diether compounds and intermediates thereof | Takasago International Corporation (JP) | 2004-04-07 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10336966-B2 | Fragrance compositions and uses thereof | CUTA, DPM1, PLIN5 | ABCG2 3483/4885ITGB2 3262/4885ICAM1 3331/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.